A Phase II Study of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) in Patients With Advanced Prostate Cancerr
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2013
At a glance
- Drugs OCX 191 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Vion Pharmaceuticals
- 02 Jan 2008 Status changed from in progress to completed.
- 25 Nov 2006 New trial record.